tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RZLT Stock Latest News

Rezolute appoints Karnawat as Chief Commercial Officer
The FlyRezolute appoints Karnawat as Chief Commercial Officer
3d ago
CYTK
RARE
Rezolute Appoints New Chief Commercial Officer
PremiumCompany Announcements
Rezolute Appoints New Chief Commercial Officer
3d ago
8K
RZLT
Rezolute Completes Enrollment for Phase 3 sunRIZE Study
PremiumCompany Announcements
Rezolute Completes Enrollment for Phase 3 sunRIZE Study
1M ago
8K
RZLT
Rezolute files to sell 1.3M shares of common stock for holders
PremiumThe Fly
Rezolute files to sell 1.3M shares of common stock for holders
1M ago
RZLT
Promising Future for Rezolute’s Ersodetug in Treating Congenital Hyperinsulinism: Analyst Recommends Buy
PremiumRatings
Promising Future for Rezolute’s Ersodetug in Treating Congenital Hyperinsulinism: Analyst Recommends Buy
1M ago
RZLT
Positive Buy Rating for Rezolute Driven by Promising Phase 3 Study Results and Strong Efficacy Potential
PremiumRatingsPositive Buy Rating for Rezolute Driven by Promising Phase 3 Study Results and Strong Efficacy Potential
1M ago
RZLT
Rezolute Completes Private Stock Placement for $4.2M
Premium
Company Announcements
Rezolute Completes Private Stock Placement for $4.2M
2M ago
8K
RZLT
Rezolute’s Promising Outlook: Buy Rating Backed by Strong Clinical Progress and Financial Position
Premium
Ratings
Rezolute’s Promising Outlook: Buy Rating Backed by Strong Clinical Progress and Financial Position
3M ago
RZLT
Rezolute complete enrollment in Phase 3 sunRIZE study of ersodetug
PremiumThe Fly
Rezolute complete enrollment in Phase 3 sunRIZE study of ersodetug
3M ago
RZLT
Rezolute, Inc. (RZLT) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Rezolute, Inc. (RZLT) Q3 Earnings Cheat Sheet
3M ago
RZLT
Rezolute’s Financial Stability and Clinical Progress Drive Buy Rating Amid Promising Phase 3 Trials
PremiumRatings
Rezolute’s Financial Stability and Clinical Progress Drive Buy Rating Amid Promising Phase 3 Trials
3M ago
RZLT
Rezolute’s Promising Market Position and Clinical Advancements Drive Buy Rating
PremiumRatings
Rezolute’s Promising Market Position and Clinical Advancements Drive Buy Rating
3M ago
RZLT
Rezolute’s Ersodetug Shows Promise in Phase 3 Trials for CHI, Reinforcing Buy Rating and $12 Price Target
PremiumRatingsRezolute’s Ersodetug Shows Promise in Phase 3 Trials for CHI, Reinforcing Buy Rating and $12 Price Target
3M ago
RZLT
Optimistic Buy Rating for Rezolute Driven by Promising Ersodetug Developments and Strong Financial Position
Premium
Ratings
Optimistic Buy Rating for Rezolute Driven by Promising Ersodetug Developments and Strong Financial Position
3M ago
RZLT
Rezolute reports Q3 EPS (27c), consensus (24c)
Premium
The Fly
Rezolute reports Q3 EPS (27c), consensus (24c)
3M ago
RZLT
Rezolute’s Ersodetug Gains Momentum with Breakthrough Therapy Designation and Promising Market Potential
PremiumRatings
Rezolute’s Ersodetug Gains Momentum with Breakthrough Therapy Designation and Promising Market Potential
4M ago
RZLT
Rezolute announces FDA granted BTD to ersodetug
PremiumThe Fly
Rezolute announces FDA granted BTD to ersodetug
4M ago
RZLT
Rezolute Closes $96.9 Million Underwritten Offering
PremiumCompany Announcements
Rezolute Closes $96.9 Million Underwritten Offering
4M ago
8K
RZLT
Douglas Tsao’s Buy Rating on Rezolute: Strong Financial Position and Promising Pipeline Boost Confidence
PremiumRatings
Douglas Tsao’s Buy Rating on Rezolute: Strong Financial Position and Promising Pipeline Boost Confidence
4M ago
RZLT
H.C. Wainwright keeps Buy on Rezolute after no changes to sunRIZE sample size
PremiumThe FlyH.C. Wainwright keeps Buy on Rezolute after no changes to sunRIZE sample size
4M ago
RZLT
Rezolute Announces Pricing of Direct Stock Offering
Premium
Company Announcements
Rezolute Announces Pricing of Direct Stock Offering
4M ago
8K
RZLT
Rezolute’s Promising Clinical Developments and Positive Outlook: A Buy Recommendation by Yun Zhong
Premium
Ratings
Rezolute’s Promising Clinical Developments and Positive Outlook: A Buy Recommendation by Yun Zhong
4M ago
RZLT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >